BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19851887)

  • 21. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
    Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
    Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic features of Lynch syndrome in the Israeli population.
    Goldberg Y; Barnes-Kedar I; Lerer I; Halpern N; Plesser M; Hubert A; Kadouri L; Goldshmidt H; Solar I; Strul H; Rosner G; Baris HN; Peretz T; Levi Z; Kariv R
    Clin Genet; 2015 Jun; 87(6):549-53. PubMed ID: 25430799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.
    Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM
    Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
    Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
    Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A636P testing in Ashkenazi Jews.
    Guillem JG; Moore HG; Palmer C; Glogowski E; Finch R; Nafa K; Markowitz AJ; Offit K; Ellis NA
    Fam Cancer; 2004; 3(3-4):223-7. PubMed ID: 15516845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of mismatch repair gene mutations in Turkish HNPCC patients.
    Tunca B; Pedroni M; Cecener G; Egeli U; Borsi E; Zorluoglu A; Di Gregorio C; Yilmazlar T; Yerci O; de Leon MP
    Fam Cancer; 2010 Sep; 9(3):365-76. PubMed ID: 20373145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
    Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
    Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
    Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
    Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
    Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
    Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.
    Goel A; Xicola RM; Nguyen TP; Doyle BJ; Sohn VR; Bandipalliam P; Rozek LS; Reyes J; Cordero C; Balaguer F; Castells A; Jover R; Andreu M; Syngal S; Boland CR; Llor X
    Gastroenterology; 2010 May; 138(5):1854-62. PubMed ID: 20102720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of hereditary non-polyposis syndrome (Lynch syndrome)].
    Kariv R; Goldberg Y; Soler I; Rosner G; Half E; Moshkowitz M; Vilkin A; Levi Z; Niv Y
    Harefuah; 2011 Apr; 150(4):392-6, 416. PubMed ID: 22164924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MSH6 germline mutations are rare in colorectal cancer families.
    Peterlongo P; Nafa K; Lerman GS; Glogowski E; Shia J; Ye TZ; Markowitz AJ; Guillem JG; Kolachana P; Boyd JA; Offit K; Ellis NA
    Int J Cancer; 2003 Nov; 107(4):571-9. PubMed ID: 14520694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-phenotype correlation in MMR mutation-positive families with Lynch syndrome.
    Pérez-Cabornero L; Infante M; Velasco E; Lastra E; Miner C; Durán M
    Int J Colorectal Dis; 2013 Sep; 28(9):1195-201. PubMed ID: 23588873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
    Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
    J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Need of new clinical criteria for the identification of genetic Lynch syndrome].
    Sousa R; Lage P; Ferreira S; Claro I; Francisco I; Filipe B; Albuquerque C; Suspiro A; Rodrigues P; Nobre-Leitão C
    Acta Med Port; 2007; 20(6):535-42. PubMed ID: 18331697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.